20.109(F11): Synthetic Lethality in Treating Medulloblastoma: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
No edit summary |
|||
| Line 1: | Line 1: | ||
=<center>Synthetic Lethality in Treating Medulloblastoma</center>= | =<center>Synthetic Lethality in Treating Medulloblastoma</center>= | ||
== References == | |||
*Tanori, M., Mancuso, M., Pasquali1, E., Leonardi, S., Rebessi, S., Majo, V.D., Guilly, M.N., Giangaspero, F., Covelli, V., Pazzaglia, S., Saran, A. (2008). PARP-1 cooperates with Ptc1 to suppress medulloblastoma and basal cell carcinoma. Carcinogenesis, 29(10), 1911–1919. http://carcin.oxfordjournals.org/content/29/10/1911.full.pdf. | |||
Revision as of 20:58, 29 November 2011
Synthetic Lethality in Treating Medulloblastoma
References
- Tanori, M., Mancuso, M., Pasquali1, E., Leonardi, S., Rebessi, S., Majo, V.D., Guilly, M.N., Giangaspero, F., Covelli, V., Pazzaglia, S., Saran, A. (2008). PARP-1 cooperates with Ptc1 to suppress medulloblastoma and basal cell carcinoma. Carcinogenesis, 29(10), 1911–1919. http://carcin.oxfordjournals.org/content/29/10/1911.full.pdf.
